Auto generated snapshot names are created in YYYY.MM.DD-HH.MM.SS format. It is recommended to add the following properties to the Samba configuration file to allow access to Previous Versions in ...

The Fanatec ClubSport GT Cockpit certainly looks the part, and the good news is that its feature set, ease of use and overall performance make it a really compelling rig option for sim racers, albeit ...

To customize how your Tropy item is mapped to CSL/JSON and Zotero, duplicate your Tropy template in Tropy's template editor and assign each field you want to export a CSL/JSON field by setting the ...

Australia’s earnings season kept the ASX in positive territory at lunchtime in the eastern states, with big banks and CSL doing the heavy lifting. Around 1pm (AEDT) the ASX 200 was up 25.60 points or ...

CSL granted Eli Lilly certain rights for clazakizumab CSl to receive upfront payment of $100 million CSL shares up 2.1% CSL will retain exclusive rights to develop and commercialise clazakizumab for ...

The most recent earnings report from CSL Limited (ASX:CSL) was disappointing for shareholders. Despite the soft profit numbers, our analysis has optimistic about the overall quality of the income ...

Australia has one of the highest documented rates of anaphylaxis hospital admissions in the developed world. 5 Between 2015 and 2020, Australian public hospitals reported a 51% increase in emergency ...

All hope might not be lost with this fallen angel. It's not hard to see why. CSL reported revenues of US$8.3 billion, a drop of 4% over the same period last year. Reported net profits after tax (NPAT) ...

One day after CSL suddenly replaced its CEO, the company provided dismal financial figures that helped explain why. In its half-year report, CSL said its net profit plummeted (PDF) from $2 billion in ...

It's been a sad week for CSL Limited (ASX:CSL), who've watched their investment drop 16% to AU$152 in the week since the company reported its interim result. Revenues came in 2.7% below expectations, ...

CSL’s share slump following weak profits and a sudden CEO exit has pulled Australian healthcare stocks to multi-year lows, highlighting sector-wide concerns over regulation and investor sentiment. CSL ...

The worst US flu season in decades did not shield one of Australia’s largest companies, biotechnology firm CSL, from another brutal market response as vaccine scepticism from Trump administration ...